Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease

Coronary Artery Disease

Volumn 24, Issue 1, 2013, Pages 29-32

  Turfan, Murat ^a   Duran, Mustafa ^b   Poyraz, Fatih ^c   Yayla, Cagri ^c   Akboga, Mehmet K ^c   Sahinarslan, Asife ^c   Tavil, Yusuf ^c   Pasaoglu, Hatice ^c   Boyaci, Bulent ^c  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b KAYSERI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

bilirubin; coronary artery disease; Syntax score

Indexed keywords

BILIRUBIN; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SYNTAX SCORE;

AGED; BILIRUBIN; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84871726884     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32835b0c13     Document Type: Article

References (26)

1. Bassenge E, Schneider HT, Daiber A. Oxidative stress and cardiovascular diseases. Dtsch Med Wochenschr 2005; 130:2904-2909.
2. Tinkel J, Hassanain H, Khouri SJ. Cardiovascular antioxidant therapy: a review of supplements, pharmacotherapies, and mechanisms. Cardiol Rev 2012; 20:77-83.
3. Jansen T, Daiber A. Direct antioxidant properties of bilirubin and biliverdin. Is there a role for biliverdin reductase? Front Pharmacol 2012; 3:30.
4. Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009; 40:3422-3427.
5. Zhang ZY, Bian LQ, Kim SJ, Zhou CC, Choi YH. Inverse relation of total serum bilirubin to coronary artery calcification score detected by multidetector computed tomography in males. Clin Cardiol 2012; 35: 301-306.
6. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 2003; 228:568-571.
7. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, et al. Association between the UGT1A1, 28 allele, bilirubin levels, and coronary heart disease in the framingham heart study. Circulation 2006; 114:1476-1481.
8. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005; 1:219-227.
9. Lansky AJ, Ng VG, Maehara A,Weisz G, Lerman A, Mintz GS, et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging 2012; 5 (3 Suppl):S62-S72.
10. Nurkalem Z, Hasdemir H, Ergelen M, Aksu H, Sahin I, Erer B, et al. The relationship between glucose tolerance and severity of coronary artery disease using the Gensini score. Angiology 2010; 61:751-755.
11. Koukoulaki M, Papachristou E, Kalogeropoulou C, Papathanasiou M, Zampakis P, Vardoulaki M, et al. Increased prevalence and severity of coronary artery calcification in patients with chronic kidney disease stage III and IV. Nephron Extra 2012; 2:192-204.
12. Ozaki Y, Imanishi T, Taruya A, Aoki H, Masuno T, Shiono Y, et al. Circulating CD14+ CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris. Circ J 2012; 76:2412-2418.
13. Isik T, Uyarel H, Tanboga IH, Kurt M, Ekinci M, Kaya A, et al. Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease. Coron Artery Dis 2012; 23:51-56.
14. Zhang WP, Yuan ZY, Liu Y, Jia L, Cheng H, Qi J, et al. Risk factors and coronary angiographic findings in young and elderly patients with acute myocardial infarction: a comparative analysis. Nan Fang Yi Ke Da Xue Xue Bao 2008; 28:718-721.
15. Lim S, Choi HJ, Shin H, Khang AR, Kang SM, Yoon JW, et al. Subclinical atherosclerosis in a community-based elderly cohort: the Korean longitudinal study on health and aging. Int J Cardiol 2012; 155:126-133.
16. Jin Z, Zhang Y, Chen J, Zhu J, Zhang F, Qiu Y, et al. Study of the correlation between blood lipid levels and the severity of coronary atherosclerosis in a Chinese population sample. Acta Cardiol 2006; 61:603-606.
17. Xiong Z, Zhu C, Zheng Z, Wang M, Wu Z, Chen L, et al. Relationship between arterial stiffness assessed by brachial-ankle pulse wave velocity and coronary artery disease severity assessed by the SYNTAX score. J Atheroscler Thromb 2012 [Epub ahead of print].
18. Moon JY, Kwon HM, Kwon SW, Yoon SJ, Kim JS, Lee SJ, et al. Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease. Cardiology 2007; 108:282-289.
19. Stocker R,Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043-1046.
20. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994; 40:18-23.
21. Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrieres J, et al. Bilirubin and coronary heart disease risk in the prospective epidemiological study of myocardial infarction (PRIME). Eur J Cardiovasc Prev Rehabil 2007; 14:79-84.
22. Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S, Gottschall CA. Serum bilirubin concentration in patients with an established coronary artery disease. Int Heart J 2010; 51:86-91.
23. Sahin O, Akpek M, Elcik D, Karadavut S, Simsek V, Tulmac M, et al. Bilirubin levels and the burden of coronary atherosclerosis in patients with STEMI. Angiology 2012 [Epub ahead of print].
24. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994; 269:16712-16719.
25. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000; 46:1723-1727.
26. Yoshino S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Oketani N, et al. Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol. Heart Vessels 2012 [Epub ahead of print].